Fiera Capital (Canada)
OCDX

Fiera Capital (Canada)’s Ortho Clinical Diagnostics Holdings plc Ordinary Shares OCDX Stock Holding History

Fiera Capital (Canada)’s Portfolio OCDX Stock Details OCDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-759,696
Closed -$14.2M – 621
2022
Q1 		$14.2M Buy
759,696
+29,540
+4% +$532K 0.04% 165
2021
Q4 		$15.6M Buy
730,156
+35,566
+5% +$701K 0.04% 166
2021
Q3 		$12.8M Buy
694,590
+197,171
+40% +$3.97M 0.03% 164
2021
Q2 		$10.7M Buy
497,419
+86,412
+21% +$1.76M 0.03% 159
2021
Q1 		$7.93M Buy
+411,007
New +$7.24M 0.02% 166

Other funds holding OCDX

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Fiera Capital (Canada)'s OCDX Position: Q2 2022 in Review

Fiera Capital (Canada) sold out of Ortho Clinical Diagnostics Holdings plc Ordinary Shares (OCDX) in Q2 2022, closing a stake of 759,696 shares — an estimated $14.2M sold.

Fiera Capital (Canada) first reported a position in OCDX in Q1 2021 and held it in 5 quarters. The position peaked at $15.6M in Q4 2021. 1 fund tracked by Wall St. Rank holds OCDX as of Q2 2022.

  • Fiera Capital (Canada) reported no remaining Ortho Clinical Diagnostics Holdings plc Ordinary Shares position as of Q2 2022 after selling out during the quarter.
  • Fiera Capital (Canada) sold 759,696 Ortho Clinical Diagnostics Holdings plc Ordinary Shares shares in Q2 2022, an estimated $14.2M.
  • Fiera Capital (Canada) first reported a position in Ortho Clinical Diagnostics Holdings plc Ordinary Shares in Q1 2021 and held it in 5 quarters.
  • Fiera Capital (Canada)'s Ortho Clinical Diagnostics Holdings plc Ordinary Shares position peaked at $15.6M in Q4 2021.
  • 1 fund tracked by Wall St. Rank held Ortho Clinical Diagnostics Holdings plc Ordinary Shares as of Q2 2022.

Based on Fiera Capital (Canada)'s 13F filing for Q2 2022, filed 10 Aug 2022.